/ Home Blog All In Vitro Evaluation of the Activity of Terpenes and Cannabidiol against Human Coronavirus E229

Top sellers

All best sellers

Information

Tags

New
Blog navigation

Search in blog

Latest posts

View all latest posts

In Vitro Evaluation of the Activity of Terpenes and Cannabidiol against Human Coronavirus E229

712 Views Posted on: 2022-01-12

The activity of a new, terpene-based formulation, code-named NT-VRL-1, against Human Coronavirus (HCoV) strain 229E was evaluated in human lung fibroblasts (MRC-5 cells), with and without the addition of cannabidiol (CBD). The main constituents in the terpene formulation used for the experiment were beta caryophyllene, eucalyptol, and citral. The tested formulation exhibited an antiviral effect when it was pre-incubated with the host cells prior to virus infection. The combination of NT-VRL-1 with CBD potentiated the antiviral effect better than the positive controls pyrazofurin and glycyrrhizin. There was a strong correlation between the quantitative results from a cell-viability assay and the cytopathic effect seen under the microscope after 72 h. To the best of our knowledge, this is the first report of activity of a combination of terpenes and CBD against a coronavirus.

 

Read more here: HTTPS://WWW.NCBI.NLM.NIH.GOV/PMC/ARTICLES/PMC8065867/

Was this blog post helpful to you?
Posted in: All

Leave a comment

Security code

Related posts

Stay connected

Our website processes cookies in order to increase the user-friendliness of the website and, in the case of your consent, to personalize ads. More info

 close

Disclaimer

This website is an initiative of the company Sciva International s.r.o., which has its head office in Prague, the Czech Republic.

Sciva International s.r.o. shall not be held liable for the medical claims made by customers. It should be noted that these products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care professionals. Sciva International s.r.o. does not make any health claims about our products except those officially approved by EFSA and recommends consulting with health care professionals prior to consuming our products. It is especially important for those who are pregnant, nursing, chronically ill, elderly to discuss the use of these products with health care professionals. You must be 18 years or older to visit this website and/or purchase the products. The website may contain references in the form of hyperlinks, banners or buttons for example, to third party websites. Sciva International s.r.o. has no authority over these websites. The rights relating to this website, including those of intellectual ownership, copyright on text, streaming videos, images, design, data files, photographs and other (moving or stationary) visual material, audio material, formats, software, brands (including domain names) and other material are held by Sciva International s.r.o. and/or its licensing body.

© 2024 Sciva Corporation s.r.o. All Rights Reserved.



Cookies Consent to processing of personal data

© 2024 Sciva Corporation s.r.o. All Rights Reserved.

Are you more than
18 years of age?

Yes No